Mia's Feed
Medical News & Research

Innovative Charts for Artery Stiffness Enable Early Detection of Heart Risks in Youth

Innovative Charts for Artery Stiffness Enable Early Detection of Heart Risks in Youth

Share this article

New reference charts for pulse wave velocity enable early detection of cardiovascular risks in children and young adults, paving the way for proactive interventions decades before symptoms appear.

2 min read

Researchers from an international consortium have developed the first comprehensive reference charts for assessing blood vessel stiffness in healthy children, adolescents, and young adults. This breakthrough offers a powerful tool for pediatric and adolescent healthcare providers to identify signs of cardiovascular risk decades before clinical symptoms appear. Pulse wave velocity (PWV), a key measure of arterial flexibility, reflects how quickly pressure waves from the heart travel through blood vessels. Increased stiffness, indicated by higher PWV scores, is associated with a greater likelihood of future heart attacks and strokes.

The recent analysis, published in Hypertension, evaluated data from nearly 20,000 participants aged 1 to 40, all of whom met strict criteria for health status, including blood pressure, BMI, and cholesterol levels. Pulse wave velocity testing is noninvasive and involves simple measurements with a cuff and a tonometer, making it accessible and affordable for routine clinical use.

One of the major challenges was that six different brands of PWV devices use incompatible algorithms, preventing standardized interpretation. The consortium addressed this by establishing normative percentiles by age and sex, akin to growth charts, enabling clinicians to interpret individual scores relative to age-based norms. This effort involved large-scale data collection across multiple countries, emphasizing that arterial stiffness naturally increases with age but continues to do so beyond puberty.

Early detection of elevated PWV in young people could inform targeted interventions, such as medication or lifestyle changes, before the development of arterial damage. Certain blood pressure medications are known to reduce arterial stiffness, and PWV testing could help tailor treatment choices.

These reference charts lay the groundwork for further research, including long-term studies and registries, to refine optimal management strategies. As arterial stiffness can serve as a vital early marker of cardiovascular health, integrating PWV testing into routine exams could revolutionize preventive care from childhood onward.

Overall, this advancement marks a significant step in proactive cardiovascular health management in youth, highlighting the importance of early detection and intervention in reducing future heart disease risk.

Source: https://medicalxpress.com/news/2025-09-artery-stiffness-flag-heart-symptoms.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Deciding on a Tracheostomy for Your Sick Baby: Navigating the Emotional and Practical Challenges

Choosing a tracheostomy for a sick infant is a life-saving but emotionally taxing decision. This article explores the emotional, practical, and support strategies for families facing this challenging choice.

Breakthrough in Genetic Research Leads to Personalized Treatments for Rare Skin Disorder

A groundbreaking genetic study discovers a new mutation in EMP2 causing a rare skin disorder, leading to targeted therapy options using EGFR inhibitors like erlotinib.

Understanding Chronic Venous Insufficiency and Its Significance in Health

Chronic venous insufficiency (CVI) is a common condition affecting leg veins, linked to increased cardiovascular risk. Early detection and treatment are essential for better health outcomes.

Shorter Radiation Treatment Shows Improved Patient Experience but Similar Disease Control in Intermediate-Risk Prostate Cancer

A large phase III trial reveals that five-session stereotactic body radiation therapy improves quality of life for intermediate-risk prostate cancer patients, with similar disease control compared to longer courses.